Target intelligence / Profile preview

Elongin C pseudogene 14 (ELOCP14)

Target: ELOCP14
Molecular classification: Other (Pseudogene)

Overview

Elongin C pseudogene 14 (ELOCP14) is a human pseudogene related to the elongin C (ELOC) gene, which is a component of the transcription factor B (SIII) complex and plays a role in transcription elongation by RNA polymerase II. However, ELOCP14 itself is considered nonfunctional, meaning it does not encode a functional protein product or participate in regulatory pathways associated with therapeutic targets. Unlike the functional elongin C (ELOC), pseudogenes like ELOCP14 typically do not have direct biological functions or disease associations, and there are no known drugs, biomarkers, or therapeutic uses related to this pseudogene.

Other names: TCEB1P14

Beyond the preview

Go deeper on Elongin C pseudogene 14 (ELOCP14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 14 (ELOCP14).

Explore the full profile